|
1
|
Zhang Y, He X, Liu Y, et al: microRNA-320a
inhibits tumor invasion by targeting neuropilin 1 and is associated
with liver metastasis in colorectal cancer. Oncol Rep. 27:685–694.
2012.
|
|
2
|
Baraniskin A, Birkenkamp-Demtroder K,
Maghnouj A, et al: MiR-30a-5p suppresses tumor growth in colon
carcinoma by targeting DTL. Carcinogenesis. 33:732–739. 2012.
|
|
3
|
Braconi C, Kogure T, Valeri N, et al:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
|
|
4
|
Chang Y, Yan W, He X, et al: miR-375
inhibits autophagy and reduces viability of hepatocellular
carcinoma cells under hypoxic conditions. Gastroenterology.
143:177–187. 2012.
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
|
|
6
|
Zeng Y, Yi R and Cullen BR: MicroRNAs and
small interfering RNAs can inhibit mRNA expression by similar
mechanisms. Proc Natl Acad Sci USA. 100:9779–9784. 2003.
|
|
7
|
Zhang LY, Liu M, Li X and Tang H:
miR-490-3p modulates cell growth and epithelial to mesenchymal
transition of hepatocellular carcinoma cells by targeting
endoplasmic reticulum-Golgi intermediate compartment protein 3
(ERGIC3). J Biol Chem. 288:4035–4047. 2012.
|
|
8
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
|
|
9
|
Xu P, Vernooy SY, Guo M and Hay BA: The
Drosophila microRNA Mir-14 suppresses cell death and is required
for normal fat metabolism. Curr Biol. 13:790–795. 2003.
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.
|
|
11
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004.
|
|
12
|
Bai S, Nasser MW, Wang B, et al:
MicroRNA-122 inhibits tumorigenic properties of hepatocellular
carcinoma cells and sensitizes these cells to sorafenib. J Biol
Chem. 284:32015–32027. 2009.
|
|
13
|
Tsai WC, Hsu PW, Lai TC, et al:
MicroRNA-122, a tumor suppressor microRNA that regulates
intrahepatic metastasis of hepatocellular carcinoma. Hepatology.
49:1571–1582. 2009.
|
|
14
|
Nie J, Liu L, Zheng W, et al:
microRNA-365, down-regulated in colon cancer, inhibits cell cycle
progression and promotes apoptosis of colon cancer cells by
probably targeting Cyclin D1 and Bcl-2. Carcinogenesis. 33:220–225.
2012.
|
|
15
|
Li Q, Zou C, Han Z, et al: MicroRNA-25
functions as a potential tumor suppressor in colon cancer by
targeting Smad7. Cancer Lett. 335:168–174. 2013.
|
|
16
|
Tang F, Zhang R, He Y, et al:
MicroRNA-125b Induces metastasis by targeting STARD13 in MCF-7 and
MDA-MB-231 breast cancer cells. PloS One. 7:e354352012.
|
|
17
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004.
|
|
18
|
Piepoli A, Tavano F, Copetti M, et al:
Mirna expression profiles identify drivers in colorectal and
pancreatic cancers. PLoS One. 7:e336632012.
|
|
19
|
Necela BM, Carr JM, Asmann YW and Thompson
EA: Differential expression of microRNAs in tumors from chronically
inflamed or genetic (APC(Min/+)) models of colon cancer. PLoS One.
6:e185012011.
|
|
20
|
Cekaite L, Rantala JK, Bruun J, et al:
MiR-9, -31, and -182 deregulation promote proliferation and tumor
cell survival in colon cancer. Neoplasia. 14:868–879. 2012.
|
|
21
|
Alder H, Taccioli C, Chen H, et al:
Dysregulation of miR-31 and miR-21 induced by zinc deficiency
promotes esophageal cancer. Carcinogenesis. 33:1736–1744. 2012.
|
|
22
|
Su SF, Chang YW, Andreu-Vieyra C, et al:
miR-30d, miR-181a and miR-199a-5p cooperatively suppress the
endoplasmic reticulum chaperone and signaling regulator GRP78 in
cancer. Oncogene. 32:4694–4701. 2012.
|
|
23
|
Liu X, Cheng Y, Chen X, et al: MicroRNA-31
regulated by the extracellular regulated kinase is involved in
vascular smooth muscle cell growth via large tumor suppressor
homolog 2. J Biol Chem. 286:42371–42380. 2011.
|
|
24
|
Song T, Zhang X, Zhang L, et al: miR-708
promotes the development of bladder carcinoma via direct repression
of Caspase-2. J Cancer Res Clin Oncol. 139:1189–1198. 2013.
|
|
25
|
Sabates-Bellver J, Van der Flier LG, de
Palo M, et al: Transcriptome profile of human colorectal adenomas.
Mol Cancer Res. 5:1263–1275. 2007.
|
|
26
|
Nieminen TT, Shoman S, Eissa S, Peltomäki
P and Abdel-Rahman WM: Distinct genetic and epigenetic signatures
of colorectal cancers according to ethnic origin. Cancer Epidemiol
Biomarkers Prev. 21:202–211. 2012.
|
|
27
|
Gonzalez-Zulueta M, Bender CM, Yang AS, et
al: Methylation of the 5′ CpG island of the p16/CDKN2 tumor
suppressor gene in normal and transformed human tissues correlates
with gene silencing. Cancer Res. 55:4531–4535. 1995.
|
|
28
|
Shi T, Mazumdar T, Devecchio J, et al:
cDNA microarray gene expression profiling of hedgehog signaling
pathway inhibition in human colon cancer cells. PLoS One.
5:e130542010.
|
|
29
|
Choi S, Kim TW and Singh SV: Ginsenoside
Rh2-mediated G1 phase cell cycle arrest in human breast cancer
cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of
cyclin-dependent kinases. Pharm Res. 26:2280–2288. 2009.
|
|
30
|
Bambang IF, Xu S, Zhou J, et al:
Overexpression of endoplasmic reticulum protein 29 regulates
mesenchymal-epithelial transition and suppresses xenograft tumor
growth of invasive breast cancer cells. Lab Invest. 89:1229–1242.
2009.
|
